Page last updated: 2024-11-02

pantoprazole and Deficiency, Magnesium

pantoprazole has been researched along with Deficiency, Magnesium in 3 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhana, A1
Waters, MJ1
Fazal, MW1
Kimber, T1
Fernández-Fernández, FJ1
Sesma, P1
Caínzos-Romero, T1
Ferreira-González, L1
Famularo, G1
Minisola, G1
Bravi, MC1
Colucci, P1
Gasbarrone, L1

Other Studies

3 other studies available for pantoprazole and Deficiency, Magnesium

ArticleYear
Pantoprazole-induced hypomagnesaemia causing cerebellar syndrome and seizures.
    Internal medicine journal, 2017, Volume: 47, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Cerebellar Diseases; Female; Humans; Magnesium Defici

2017
Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
    The Netherlands journal of medicine, 2010, Volume: 68, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonis

2010
Tetany, hypomagnesemia, and proton-pump inhibitors.
    The American journal of medicine, 2012, Volume: 125, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium;

2012